Pure Biologics S.A. (WSE:PUR)

Poland flag Poland · Delayed Price · Currency is PLN
6.11
+1.41 (29.89%)
Jul 18, 2025, 5:01 PM CET
-62.55%
Market Cap24.92M
Revenue (ttm)n/a
Net Income (ttm)-15.80M
Shares Out4.08M
EPS (ttm)-4.34
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume278,533
Average Volume185,235
Open4.79
Previous Close4.70
Day's Range4.60 - 6.40
52-Week Range2.22 - 33.20
Beta1.16
RSI65.14
Earnings DateSep 9, 2025

About Pure Biologics

Pure Biologics S.A., a biopharmaceutical company, engages in the research and development of biological drugs and non-systematic therapies in the field of immuno-oncology, autoimmunology, and rare neurological diseases. It is involved in the production, purification, analysis, and characterization of antibodies and aptamers; and design, development, and validation of assays, as well as conducts research on technology platforms for selecting active molecules. The company offers PureApta, a modular platform for in vitro selection of modified apta... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 7
Stock Exchange Warsaw Stock Exchange
Ticker Symbol PUR
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.